Manuscripts
Showing 1533 manuscripts.
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
Citation
Philip Keiser, David Alain Wohl, Michelle A. Kendall, Janet Andersen, Clyde S. Crumpacker, Stephen A. Spector, Judith Feinberg, Beverly L. Alston-Smith, Susan Owens, Suzette A. Chafey, Michael Marco, Sharon D. Maxwell-Henkel, Nell Lurain, Douglas Jabs, Constance A. Benson. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.. HIV Clinical Trials. 2009. 10: 143-52. PMID: 19632953Year
2009
Journal
HIV Clinical Trials
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)
Citation
David B. Clifford, Scott Evans, Yijun Yang, Edward P. Acosta, Heather Ribaudo, Roy (Trip) Gulick. Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clinical Trials. 2009. 10: 343-55.Year
2009
Journal
HIV Clinical Trials
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients
Citation
David B. Clifford, Marlene Smurzynski, Lesley Suejean Park, Tzu-min Yeh, Yu Zhao, Laura L. Blair, Max Arens, Scott Evans. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 2009. 73: 309-14. PMID: 19636051Year
2009
Journal
Neurology
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
Citation
Susan Moir, Angelina Malaspina, Irini Sereti, Michel Morre, Richard Dunham, Renaud Buffet, John Spritzler, Guido Silvestri, Evgenia Aga, Michael M. Lederman, Michael Proschan, Kathleen A. Medvik, Cathy Battaglia, Alan Landay, Savita G. Pahwa, Margaret A. Fischl, David M. Asmuth, Allan R. Tenorio, John Altman, Lawrence Fox. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009. 113: 6304-14.Year
2009
Journal
Blood
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients
Citation
Lisa M. Demeter, Hongyu Jiang, Lisa Mukherjee, Gene D. Morse, Robin DiFrancesco, Robert DiCenzo, Carrie Dykes, Prakash Sista, Lee Bacheler, Karin L. Klingman, Alex R. Rinehart, Mary Albrecht. A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients. AIDS. 2009. 23: 357-68.Year
2009
Journal
AIDS
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection
Citation
Justin C. McArthur, Victor G. Valcour, Tzu-min Yeh, Russell Bartt, David B. Clifford, Mariana Gerschenson, Scott Evans, Bruce A. Cohen, G. J. Ebenezer, Peter Hauer, Linda L. Millar, Mary Gould, Paul T. Tran, Cecilia M. Shikuma, Scott Souza. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Medicine. 2009. 10: 103-110.Year
2009
Journal
HIV Medicine
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Citation
David W. Haas, Susan L. Koletar, Laura J. Laughlin, Michelle A. Kendall, Carol Suckow, John G. Gerber, Andrew R. Zolopa, Richard J. Bertz, Michael J. Child, Lara A. Hosey, Beverly L. Alston-Smith, Edward P. Acosta. Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.. Journal of Acquired Immune Deficiency Syndromes. 2009. 50: 290-3. PMID: 19194314Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects
Citation
Samir K. Gupta, Lauren Komarow, Roy (Trip) Gulick, Richard B. Pollard, Gregory K. Robbins, Nora Franceschini, Lynda Anne Szczech, Susan L. Koletar, Robert C Kalayjian. Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. Journal of Infectious Diseases. 2009. 200: 614-8.Year
2009
Journal
Journal of Infectious Diseases
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection
Citation
Theresa Whiteside, P. Piazza, Nancy C. Connolly, Charles Rinaldo, Sharon A. Riddler. Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. Clinical and Vaccine Immunology. 2009. 16: 233-40.Year
2009
Journal
Clinical and Vaccine Immunology
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
Citation
David W. Haas, Sharon A. Riddler, Zabrine J. Brumme, Richard H. Haubrich, Mina John, Bruce D. Walker, Jonathan Carlson, P. Richard Harrigan, Chanson J. Brumme, David Heckerman, Dennison Chan, Simon Mallal, Mark Brockman, Luke Swenson, Iris Tao, Sharon Szeto, Pamela Rosato, Jennifer Sela, Carl Kadie, Nicole Frahm, Christian Brander. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. Public Library of Science One. 2009. 4: E6687.Year
2009
Journal
Public Library of Science One